Research Article

Evaluation of Clinical and Epidemiological Features of Patients Receiving High-Flow Nasal Cannula Oxygen Therapy in the Pediatric Intensive Care Unit

Volume: 6 Number: 1 April 22, 2022
EN TR

Evaluation of Clinical and Epidemiological Features of Patients Receiving High-Flow Nasal Cannula Oxygen Therapy in the Pediatric Intensive Care Unit

Abstract

Purpose: One of the respiratory supports in acute respiratory failure (ARF) is high-flow nasal cannula (HFNC) oxygen therapy, which is being increasingly used in this study. We aimed to evaluate the patients with ARF who received HFNC oxygen therapy in the pediatric intensive care unit (ICU).
Materials and Methods: The study was done retrospectively in 104 patients who were admitted to the pediatric ICU and received HFNC oxygen therapy between January 2015 and December 2017.
Results: The median age of the patients participating in the study was 5 months. The most common cause of hospitalization was lower respiratory disease (97.1%), and 52.9% of the patients had type 1 respiratory failure. The median length of stay in the pediatric ICU was 7 days, while the median duration of HFNC oxygen therapy was 48 hours. In patients who were intubated during HFNC oxygen therapy (28.8%), the proportions of having a chronic disease and chronic lung disease were significantly higher than those who were not intubated (p=0.001, p=0.033, respectively). In terms of complications, nasal skin damage (8.7%) and pneumothorax (1.9%) were developed. The proportions of chronic diseases and congenital heart disease of the patients who were admitted to pediatric ICU and died after HFNC oxygen therapy were significantly higher than the survivors (p=0.043, p=0.003, respectively).
Conclusion: The results of HFNC oxygen therapy, which is being increasingly used in the treatment of respiratory failure in children, are generally satisfactory. However, due to possible complications, close monitoring is required during the application.

Keywords

References

  1. 1. Mayfield S, Jauncey-Cooke J, Hough JL, Schibler A, Gibbons K, Bogossian F. High-flow nasal cannula therapy for respiratory support in children. Cochrane Database Syst Rev. 2014;2014(3):CD009850.
  2. 2. Söğütlü Y, Biçer S, Kurt G, ve ark. Alt solunum yolu hastalığı olan çocuklarda yüksek akımlı nazal kanül oksijenasyon tedavisinin yaşamsal bulgular üzerindeki sonuçları. J Pediatr Emerg Intensive Care Med. 2016;3(3):121-130.
  3. 3. Wing R, James C, Maranda LS, Armsby CC. Use of high-flow nasal cannula support in the emergency department reduces the need for intubation in pediatric acute respiratory insufficiency. Pediatr Emerg Care. 2012;28(11):1117-1123.
  4. 4. Lee JH, Rehder KJ, Williford L, Cheifetz IM, Turner DA. Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Med. 2013;39(2):247-257.
  5. 5. Slain KN, Shein SL, Rotta AT. The use of high-flow nasal cannula in the pediatric emergency department. J Pediatr (Rio J). 2017;93(1):36-45.
  6. 6. Mikalsen IB, Davis P, Øymar K. High flow nasal cannula in children: a literature review. Scand J Trauma Resusc Emerg Med. 2016;24(1):1-12.
  7. 7. Kezer S, Eryavuz Ö, Okuyan H. E, Atakan S. K, Mutlu D, Demirkol D. solunum yetersizliğinde yüksek akımlı oksijen tedavisi. Pediatri. 2018;10(3):12-18.
  8. 8. Friedman ML, Nitu ME. Acute respiratory failure in children. Pediatr Ann. 2018;47(7):268-273.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

April 22, 2022

Submission Date

February 20, 2021

Acceptance Date

July 30, 2021

Published in Issue

Year 2022 Volume: 6 Number: 1

APA
Büyükşen, O., Bayraktar, S., & Elevli, M. (2022). Evaluation of Clinical and Epidemiological Features of Patients Receiving High-Flow Nasal Cannula Oxygen Therapy in the Pediatric Intensive Care Unit. Ahi Evran Medical Journal, 6(1), 7-14. https://doi.org/10.46332/aemj.883605
AMA
1.Büyükşen O, Bayraktar S, Elevli M. Evaluation of Clinical and Epidemiological Features of Patients Receiving High-Flow Nasal Cannula Oxygen Therapy in the Pediatric Intensive Care Unit. Ahi Evran Med J. 2022;6(1):7-14. doi:10.46332/aemj.883605
Chicago
Büyükşen, Osman, Süleyman Bayraktar, and Murat Elevli. 2022. “Evaluation of Clinical and Epidemiological Features of Patients Receiving High-Flow Nasal Cannula Oxygen Therapy in the Pediatric Intensive Care Unit”. Ahi Evran Medical Journal 6 (1): 7-14. https://doi.org/10.46332/aemj.883605.
EndNote
Büyükşen O, Bayraktar S, Elevli M (April 1, 2022) Evaluation of Clinical and Epidemiological Features of Patients Receiving High-Flow Nasal Cannula Oxygen Therapy in the Pediatric Intensive Care Unit. Ahi Evran Medical Journal 6 1 7–14.
IEEE
[1]O. Büyükşen, S. Bayraktar, and M. Elevli, “Evaluation of Clinical and Epidemiological Features of Patients Receiving High-Flow Nasal Cannula Oxygen Therapy in the Pediatric Intensive Care Unit”, Ahi Evran Med J, vol. 6, no. 1, pp. 7–14, Apr. 2022, doi: 10.46332/aemj.883605.
ISNAD
Büyükşen, Osman - Bayraktar, Süleyman - Elevli, Murat. “Evaluation of Clinical and Epidemiological Features of Patients Receiving High-Flow Nasal Cannula Oxygen Therapy in the Pediatric Intensive Care Unit”. Ahi Evran Medical Journal 6/1 (April 1, 2022): 7-14. https://doi.org/10.46332/aemj.883605.
JAMA
1.Büyükşen O, Bayraktar S, Elevli M. Evaluation of Clinical and Epidemiological Features of Patients Receiving High-Flow Nasal Cannula Oxygen Therapy in the Pediatric Intensive Care Unit. Ahi Evran Med J. 2022;6:7–14.
MLA
Büyükşen, Osman, et al. “Evaluation of Clinical and Epidemiological Features of Patients Receiving High-Flow Nasal Cannula Oxygen Therapy in the Pediatric Intensive Care Unit”. Ahi Evran Medical Journal, vol. 6, no. 1, Apr. 2022, pp. 7-14, doi:10.46332/aemj.883605.
Vancouver
1.Osman Büyükşen, Süleyman Bayraktar, Murat Elevli. Evaluation of Clinical and Epidemiological Features of Patients Receiving High-Flow Nasal Cannula Oxygen Therapy in the Pediatric Intensive Care Unit. Ahi Evran Med J. 2022 Apr. 1;6(1):7-14. doi:10.46332/aemj.883605

Ahi Evran Medical Journal  is indexed in ULAKBIM TR Index, Turkish Medline, DOAJ, Index Copernicus, EBSCO and Turkey Citation Index. Ahi Evran Medical Journal is periodical scientific publication. Can not be cited without reference. Responsibility of the articles belong to the authors.

    Creative Commons Lisansı

This journal is licensed under the Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı.